The Covid-19 (coronavirus) pandemic is impacting society and the overall economy across the world. The impact of this pandemic is growing day by day as well as affecting the supply chain. The COVID-19 crisis is creating uncertainty in the stock market, massive slowing of supply chain, falling business confidence, and increasing panic among the customer segments. The overall effect of the pandemic is impacting the production process of several industries including Life Science, and many more. Trade barriers are further restraining the demand- supply outlook.
Dengue is a vector-borne disease caused due to virus that belongs to the Flaviviridae family and genus Flavivirus. Dengue fever is developed to a person who is bitten by infected Aedes aegypti mosquito. The symptoms of dengue disease include fever, headache, fatigue, muscle pain, diarrhea, anemia, skin rashes, and vomiting.
Download a Sample Report Explore further @ https://www.theinsightpartners.com/sample/TIPRE00006927
The dengue vaccine market is anticipated to grow in the forecast, owing to the factors such as increasing prevalence of the diseases, large unmet medical need for managing dengue burden, promising end stage vaccine, adoption of dengue vaccines by several countries, and promising end stage vaccine pipeline. Nevertheless, cold chain systems for storage of vaccine in resource constrained countries is expected to hamper the market growth during the forecast period.
Top Dominating Key Players:
- Sanofi Pasteur Limited
- Takeda Pharmaceutical Company Limited
- Merck Sharp & Dohme Corp
- GlaxoSmithKline plc
- GeneOne Life Science
- Medigen Vaccine Biologics
- Panacea Biotec Limited
- Sun Pharmaceutical Industries Ltd
- Serum Institute of India Pvt. Ltd
- Biological E
The global market is segmented on the basis of product and distribution channel. Based on product the market is segmented into CYD-TDV. Based on distribution channel the market is segmented into hospitals pharmacies, retail pharmacies, drug stores, online pharmacies, and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global dengue vaccine market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The dengue vaccine market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting dengue vaccine market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Dengue Vaccine market in these regions.
Request for Buy Report @ https://www.theinsightpartners.com/buy/TIPRE00006927
Reasons to Buy the Report:
- Learn about the driving factors, affecting the market growth.
- Imbibe the advancements and progress in the market during the forecast period.
- Understand where the market opportunities lies.
- Compare and evaluate various options affecting the market.
- Pick up on the leading market players within the market.
- Envision the restrictions and restrains that are likely to hamper the market.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
The Insight partners,
Email: [email protected]